EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky

Kara L. Larson; Bin Huang; Quan Chen; Thomas Tucker; Marissa Schuh; Susanne M. Arnold; Jill M. Kolesar

doi:10.1371/journal.pone.0237790

Loading metrics

Open Access

Peer-reviewed

Research Article

EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky

Kara L. Larson,

Roles Writing – original draft, Writing – review & editing

Affiliation Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America

http://orcid.org/0000-0002-4678-634X

⨯
Bin Huang,

Roles Formal analysis, Writing – review & editing

Affiliations Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America, Division of Cancer Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, United States of America
⨯
Quan Chen,

Roles Formal analysis, Writing – review & editing

Affiliation Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America
⨯
Thomas Tucker,

Roles Writing – review & editing

Affiliations Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America, Department of Epidemiology, University of Kentucky, Lexington, Kentucky, United States of America
⨯
Marissa Schuh,

Roles Writing – original draft

Affiliation Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America

http://orcid.org/0000-0003-3654-6219

⨯
Susanne M. Arnold,

Roles Conceptualization, Project administration, Writing – review & editing

Affiliations Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America, Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, United States of America
⨯
Jill M. Kolesar

Roles Conceptualization, Funding acquisition, Project administration, Writing – review & editing

* E-mail: jill.kolesar@uky.edu

Affiliations Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America, Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, United States of America
⨯

EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky

Kara L. Larson,
Bin Huang,
Quan Chen,
Thomas Tucker,
Marissa Schuh,
Susanne M. Arnold,
Jill M. Kolesar

Published: August 18, 2020
https://doi.org/10.1371/journal.pone.0237790

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Kentucky
Is the Subject Area "Kentucky" applicable to this article?

Thanks for your feedback.
Medicare
Is the Subject Area "Medicare" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Health insurance
Is the Subject Area "Health insurance" applicable to this article?

Thanks for your feedback.
Precision medicine
Is the Subject Area "Precision medicine" applicable to this article?

Thanks for your feedback.
Insurance
Is the Subject Area "Insurance" applicable to this article?

Thanks for your feedback.